日本語View as Markdown

Coaxial Fibrous Dressing Enabling Sequential NO/HRelease for Temporally Programmed Antibacterial and Healing-Promoting Functions in Infected Diabetic Wound Treatment.

同軸繊維ドレッシングによるNO/H2逐次放出を利用した糖尿病感染創傷の抗菌・治癒促進機能の時系列制御

animal study topical application positive

Abstract

A coaxial fibrous wound dressing capable of temporally programmed release of nitric oxide (NO) followed by molecular hydrogen (H2) was developed to address the complex pathology of infected diabetic wounds. The outer fiber layer, physically loaded with an NO donor, released NO at concentrations exceeding 170 μM during the initial phase, achieving bacterial eradication rates of 99.99% against Staphylococcus aureus and 99.04% against Escherichia coli, thereby facilitating resolution of the inflammatory phase. As the outer layer degraded, the inner layer became exposed, enabling near-infrared (NIR)-triggered hydrolysis of an encapsulated H2 donor for on-demand H2 release. The H2 promoted tissue repair through reactive oxygen species (ROS) scavenging and macrophage M2 polarization, as confirmed by in vitro cell assays. In a full-thickness infected skin defect model in diabetic mice, the sequential NO/H2 dressing significantly accelerated wound closure by combining rapid bactericidal action with subsequent regenerative H2 signaling.

Mechanism

The outer fiber layer releases NO rapidly to eliminate bacteria and shorten the inflammatory phase; subsequent structural degradation exposes the inner layer, where NIR irradiation triggers H2 donor hydrolysis, producing H2 that scavenges ROS and induces macrophage M2 polarization to support tissue regeneration.

Bibliographic

Authors
Hou Z, Zhang W, Li G, Cui H, Chen H, Wang T, et al.
Journal
ACS Appl Mater Interfaces
Year
2025 (2025-06-25)
PMID
40504663
DOI
10.1021/acsami.5c07099

Tags

Disease:糖尿病・代謝症候群 創傷治癒 Delivery:局所投与 Mechanism:免疫調節 炎症抑制 酸化ストレス 活性酸素種

Delivery context

Topical applications have localized-effect reports, but systemic hydrogen intake is most efficient via inhalation. Inhalation carries explosion risk (empirical LFL of 10%; high-concentration devices are not recommended).

Safety notes

Topical applications have localized-effect reports, but systemic hydrogen intake is most efficient via inhalation. Inhalation carries explosion risk (empirical LFL of 10%; high-concentration devices are not recommended).

See also:

Other papers on the same disease / condition

Cite as: H2 Papers — PMID 40504663. https://h2-papers.org/en/papers/40504663
Source: PubMed PMID 40504663